NCT05207501

Brief Summary

Aging is linked to a higher risk of cardiovascular disease. Physical exercise is recognized as an excellent strategy to prevent cardiovascular diseases and cognitive aspects, generating healthier elderly people. The beneficial effects of physical training seem to be greater when performed:

  • In hypoxic conditions (i.e. when the amount of oxygen in the air is decreased as at altitude).
  • With intermittent blood flow restriction (by inflating pneumatic cuffs around the thighs to a pressure that restricts blood flow). This equipment is harmless.
  • With eccentric training (resisting against the movement of the pedal of a bicycle rather than pushing it). The purpose of this study is then to evaluate whether moderate intensity intermittent training can induce similar or greater effects on cardiovascular health when combined with intermittent hypoxia, intermittent blood flow restriction or eccentric training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

December 23, 2021

Last Update Submit

April 25, 2023

Conditions

Keywords

HypoxiaBlood Flow RestrictionEccentric cyclingExerciceElderly

Outcome Measures

Primary Outcomes (8)

  • Blood pressure [mmHg]

    a major risk factor, when too high, for cardiovascular diseases.

    4 weeks

  • Baroreflex sensitivity

    A measurement of the mechanism that regulates acute blood pressure changes linked to the development and progression of cardiovascular diseases

    4 weeks

  • Flow-mediated dilation

    RHI index: a measure for arterial endothelial function

    4 weeks

  • Heart rate variability

    An independent predictor of cardiovascular mortality and sudden cardiac death.

    4 weeks

  • 6-Minute Cycle Test [km]

    an estimation of the maximal aerobic capacity

    4 weeks

  • Knee flexion and extension isokinetic strength [N]

    The knee flexion and extension strength will be measured with an isokinetic dynamometer

    4 weeks

  • Muscle mass [kg]

    An analysis of muscle mass will be done using DXA scan

    4 weeks

  • Body fat [kg]

    An analysis of body fat will be done using DXA scan

    4 weeks

Study Arms (4)

Moderate-intensity intermittent training (MIIT)

ACTIVE COMPARATOR

The MIIT will be conducted on a cycle ergometer (Lode Ex. calibur Sport Ergometer, Lode B.V., the Netherlands) in normoxia (FiO2 = \~ 21%). The participants will perform the MIIT starting with the ergometer resistance set to obtain the %HRmax set (\~75-80%) during 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age.

Behavioral: Exercise

MIIT during intermittent hypoxic exposure (IHYP + MIIT)

EXPERIMENTAL

A normobaric hypoxic chamber (ATS Altitude Training, Sydney, Australia) will be used for this protocol. The chamber (2.4 m x 5 m x 2.5 m) allows, via a filter and compressor system, to extract oxygen molecules and to reduce the fraction of inspired oxygen (FiO2) with no modification of the barometric pressure.

Behavioral: Exercise

MIIT during intermittent blood flow restriction (IBFR + MIIT)

EXPERIMENTAL

The IBFR + MIIT protocol will be performed while cycling in normoxia (FiO2 = \~ 21%). Elastic, pneumatic cuffs (BStrong, Park City, Utah, USA) will be administered as high as possible at the inguinal crease of the upper thigh and will be inflated during the cycling to the set pressure of 400 mmHg (except for the first training session, it will be of 250 mmHg to minimize soreness and to accustom patients to vascular occlusion training). The cuffs will be deflated at interval rest.

Behavioral: Exercise

Moderate-intensity eccentric cycling (MIEC)

EXPERIMENTAL

The MIEC will be conducted on a cycle ergometer (Excalibur, Lode, Groningen, The Nederlands) in normoxia (FiO2 = \~ 21%). The participants will be instructed to resist against the pedal movement (cadence set at 15 revolutions/min) to produce the required torque (set to obtain the 75-80%HRmax) indicated by visual feedback for 5 minutes and will rest 5 minutes after each interval of exercise. The HRmax will be considered as 200 - age. The HR responses will be monitored (Polar Electro Oy, Kempele, Finland).

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Participants will perform 3 times a week for 4 weeks a moderate intensity interval training.

MIIT during intermittent blood flow restriction (IBFR + MIIT)MIIT during intermittent hypoxic exposure (IHYP + MIIT)Moderate-intensity eccentric cycling (MIEC)Moderate-intensity intermittent training (MIIT)

Eligibility Criteria

Age65 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • to be aged between 65 and 75 years old
  • not involved in regular physical activities for at least 6 months (i.e., doing no physical exercise over twice per week);
  • free of injuries as well as cardiovascular and respiratory disorders or central nervous system disease or receiving β-blocker medication;
  • not using dietary supplements, smoking or drugs which interfere with the measurements;
  • not using creatine supplementation, anabolic steroids, drugs, or medication with potential effects on physical performance;
  • to have body index mass between 20 and 30 kg/m²;
  • not to live above 800m of altitude;
  • to be vaccinated against COVID-19 and to have no symptoms (fever, cough, fatigue, loss of smell or taste);
  • able to complete all sessions;
  • able to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Lausanne

Lausanne, Canton of Vaud, 1824, Switzerland

Location

MeSH Terms

Conditions

Hypoxia

Interventions

Exercise

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The active-control group will receives a comparable standard treatment to the three other groups: Moderate Intensity Interval Training on a ergocycle without any additional feature.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This study is designed as a randomized parallel group active-control study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 23, 2021

First Posted

January 26, 2022

Study Start

September 1, 2022

Primary Completion

March 30, 2023

Study Completion

March 30, 2023

Last Updated

April 27, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations